Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionControlled-release vaginal insert to release clindamycin antibiotic
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationBacterial vaginosis
Indication DetailsTreat bacterial vaginosis (BV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today